Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00475501Phase 2Completed
Phase 2, randomised, double-blind trial of testosterone enanthate and finasteride in male hypogonadism (4 arms), sponsored by VA Office of Research & Development. Primary endpoint: 1 Repetition Maximum Strength at 12 months. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00475501.